Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-042224

Chief Financial Officer sold 30,000 shares at an average $46.87 ($1,406,073)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-07-08 Option exercise +30,000 $6.32 $189,600 31,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2020-07-08 Sale −27,896 $46.82 $1,306,091 3,104 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2020-07-08 Sale −2,104 $47.52 $99,982 1,000 D: show line 3 in the form
Open-market sales · 30,000 sh · avg $46.87 · $1,406,073

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2020-07-08 Option exercise · Stock Option (Right To Buy) −30,000 640,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…